Metraipolis › archive › dc_07bea6d8a18a
Mortalin Represents a Promising Therapeutic Target for Oral Cancers: Clinical Relevance and Experimental Evidence for the Activation of Akt/mTOR Signaling — Europe PMC PMID:40940957
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40940957
- DOI
- 10.3390/cancers17172860
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T06:30:15.538Z
- SHA-256 of the archived text
9abb15c723a87c200845117061d048eefec3d9f521be68a79dce0a3ed046ac30- Stable URL of this page
https://metraipolis.com/documento/dc_07bea6d8a18a
How to cite
Mortalin Represents a Promising Therapeutic Target for Oral Cancers: Clinical Relevance and Experimental Evidence for the Activation of Akt/mTOR Signaling — Europe PMC PMID:40940957 — Europe PMC (en), https://europepmc.org/article/MED/40940957 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_07bea6d8a18a (Metraipolis archive dc_07bea6d8a18a, sha256 9abb15c723a87c200845117061d048eefec3d9f521be68a79dce0a3ed046ac30)
BibTeX
@misc{dc07bea6d8a18a,
title = {Mortalin Represents a Promising Therapeutic Target for Oral Cancers: Clinical Relevance and Experimental Evidence for the Activation of Akt/mTOR Signaling — Europe PMC PMID:40940957},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40940957},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_07bea6d8a18a; sha256 9abb15c723a87c200845117061d048eefec3d9f521be68a79dce0a3ed046ac30},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40940957. Agents can read the archived copy with the MCP tool read_document.